Clinical Trial Update: Omega-6/Omega-3 Ratio and Neural Development in Preterm Infants. [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/Phase 2 clinical trials evaluating how adjusting the omega-6 to omega-3 fatty acid ratio affects neural development in preterm infants with impaired psy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Impaired Psychomotor Development

Drugs mentioned

• Omega-6/Omega-3 fatty acid ratio intervention (Omega-6/Omega-3 fatty acids ratio)

Snippet

Sponsor: Ayham alshweki | Conditions: Impaired Psychomotor Development | Phase 1, Phase 2 | Status: COMPLETED